These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 34792560)
1. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers. Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560 [TBL] [Abstract][Full Text] [Related]
2. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096 [TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx. Chakravarthy A; Henderson S; Thirdborough SM; Ottensmeier CH; Su X; Lechner M; Feber A; Thomas GJ; Fenton TR J Clin Oncol; 2016 Dec; 34(34):4132-4141. PubMed ID: 27863190 [TBL] [Abstract][Full Text] [Related]
4. Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method. D'Souza G; Westra WH; Wang SJ; van Zante A; Wentz A; Kluz N; Rettig E; Ryan WR; Ha PK; Kang H; Bishop J; Quon H; Kiess AP; Richmon JD; Eisele DW; Fakhry C JAMA Oncol; 2017 Feb; 3(2):169-177. PubMed ID: 27930766 [TBL] [Abstract][Full Text] [Related]
5. Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents. D'Souza G; Anantharaman D; Gheit T; Abedi-Ardekani B; Beachler DC; Conway DI; Olshan AF; Wunsch-Filho V; Toporcov TN; Ahrens W; Wisniewski K; Merletti F; Boccia S; Tajara EH; Zevallos JP; Levi JE; Weissler MC; Wright S; Scelo G; Mazul AL; Tommasino M; Cadoni G; Brennan P Oral Oncol; 2016 Nov; 62():20-27. PubMed ID: 27865368 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival. Upadhyay R; Dhakal A; Wheeler C; Hoyd R; Jagjit Singh M; Karivedu V; Bhateja P; Bonomi M; Valentin S; Gamez ME; Konieczkowski DJ; Baliga S; Grecula JC; Blakaj DM; Gogineni E; Mitchell DL; Denko NC; Spakowicz D; Jhawar SR Cancer Biol Ther; 2024 Dec; 25(1):2350249. PubMed ID: 38722731 [TBL] [Abstract][Full Text] [Related]
7. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442 [TBL] [Abstract][Full Text] [Related]
8. Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381 [TBL] [Abstract][Full Text] [Related]
9. The interplay between HPV and host immunity in head and neck squamous cell carcinoma. Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554 [TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes in Human Papillomavirus-Associated Nonoropharyngeal Squamous Cell Carcinomas: A Systematic Review and Meta-analysis. Sahovaler A; Kim MH; Mendez A; Palma D; Fung K; Yoo J; Nichols AC; MacNeil SD JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1158-1166. PubMed ID: 33057610 [TBL] [Abstract][Full Text] [Related]
11. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma. Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222 [TBL] [Abstract][Full Text] [Related]
12. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438 [TBL] [Abstract][Full Text] [Related]
13. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. Chung CH; Zhang Q; Kong CS; Harris J; Fertig EJ; Harari PM; Wang D; Redmond KP; Shenouda G; Trotti A; Raben D; Gillison ML; Jordan RC; Le QT J Clin Oncol; 2014 Dec; 32(35):3930-8. PubMed ID: 25267748 [TBL] [Abstract][Full Text] [Related]
14. Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma. Zhu Y; Zhu X; Diao W; Liang Z; Gao Z; Chen X Clin Oral Investig; 2023 Apr; 27(4):1423-1433. PubMed ID: 36884083 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region. Ren J; Yang W; Su J; Ren X; Fazelzad R; Albert T; Habbous S; Goldstein DP; de Almeida JR; Hansen A; Jang R; Bratman SV; Hope A; Chen R; Wang J; Xu Y; Cheng D; Zhao Y; Xu W; Liu G Int J Cancer; 2019 Sep; 145(6):1465-1474. PubMed ID: 30698281 [TBL] [Abstract][Full Text] [Related]
16. HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes. Chatfield-Reed K; Gui S; O'Neill WQ; Teknos TN; Pan Q Oral Oncol; 2020 Jan; 100():104488. PubMed ID: 31835137 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas. Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511 [TBL] [Abstract][Full Text] [Related]
18. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer. Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786 [TBL] [Abstract][Full Text] [Related]
19. Type I conventional dendritic cells and CD8 Kirchner J; Plesca I; Rothe R; Resag A; Löck S; Benešová I; Rupp L; Linge A; Wehner R; Krause M; Schmitz M Front Immunol; 2024; 15():1414298. PubMed ID: 38938577 [TBL] [Abstract][Full Text] [Related]
20. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma. Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]